Cingulate (CINGW) Preferred Shares (2024 - 2025)
Cingulate's (CINGW) quarterly Preferred Shares came in at $10.0 million in Q2 2025, little changed quarter-over-quarter from $10.0 million in Q4 2024.
Powered by 
Analysis
Cingulate (CINGW) Preferred Shares (2024 - 2025) Analysis & Trends
Cingulate (CINGW) has reported Preferred Shares for 2 consecutive years, with $10.0 million the latest figure, recorded in Q2 2025.
- For the quarter ending Q2 2025, Preferred Shares changed N/A year-over-year to $10.0 million; the trailing twelve-month figure through Jun 2025 stood at $10.0 million (changed N/A YoY), and the FY2024 full-year result was $10.0 million, changed N/A from the prior year.
- Preferred Shares held at $10.0 million in Q2 2025 per CINGW's latest filing, from $10.0 million in the prior quarter.
- Across five years, Preferred Shares topped out at $10.0 million in Q4 2024 and bottomed at $10.0 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.46 Bn | 623.70 Bn | 17.26 Bn | - |
| 2 | AbbVie | 440.11 Bn | 433.54 Bn | 12.70 Bn | - |
| 3 | Merck | 365.04 Bn | 357.90 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | - |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.47 Bn | 45.09 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.26 Bn | 44.26 Bn | - | - |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn | - |
| 10 | Cingulate | 100,214.03 | 100,214.03 | - | - |